Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Ling

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
Substance Use & Misuse|June 9, 2012
HIV/AIDS and drug use in China--interactions, impacts, and issuesMin Zhao, Walter Ling
Pharmacology & Therapeutics|August 9, 2005
Medications development: successes and challengesFrank Vocci, Walter Ling
Journal of Substance Abuse Treatment|September 11, 2002
Buprenorphine: blending practice and researchWalter Ling, David Smith
Journal of Psychoactive Drugs|August 20, 2003
The Clinical Opiate Withdrawal Scale (COWS)Donald R Wesson, Walter Ling
Substance Abuse and Rehabilitation|March 21, 2014
Prescription drug overdose: between patients and their doctorsWalter Ling, Li-Tzy Wu
Drug and Alcohol Dependence|May 10, 2003
Clinical efficacy of buprenorphine: comparisons to methadone and placeboWalter Ling, Donald R Wesson
Drug and Alcohol Review|May 7, 2011
Prescription opioid abuse, pain and addiction: clinical issues and implicationsWalter Ling, Larissa Mooney, Maureen Hillhouse
Drug and Alcohol Review|September 17, 2004
Substance use and treatment options in CambodiaRachel Humeniuk, Robert Ali, Walter Ling
Drug and Alcohol Dependence|March 24, 2004
Cochrane systematic reviews: time for an introduction and appraisalWalter Ling, Michael Farrell, Robert Ali
Journal of Psychoactive Drugs|July 29, 2004
Diffusion of substance abuse treatment: will buprenorphine be a success?Walter Ling, Jerry Cunningham-Rathner, Richard Rawson
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Substance Use & Misuse|June 9, 2012
HIV/AIDS and drug use in China--interactions, impacts, and issuesMin Zhao, Walter Ling
Pharmacology & Therapeutics|August 9, 2005
Medications development: successes and challengesFrank Vocci, Walter Ling
Journal of Substance Abuse Treatment|September 11, 2002
Buprenorphine: blending practice and researchWalter Ling, David Smith
Journal of Psychoactive Drugs|August 20, 2003
The Clinical Opiate Withdrawal Scale (COWS)Donald R Wesson, Walter Ling
Substance Abuse and Rehabilitation|March 21, 2014
Prescription drug overdose: between patients and their doctorsWalter Ling, Li-Tzy Wu
Drug and Alcohol Dependence|May 10, 2003
Clinical efficacy of buprenorphine: comparisons to methadone and placeboWalter Ling, Donald R Wesson
Drug and Alcohol Review|May 7, 2011
Prescription opioid abuse, pain and addiction: clinical issues and implicationsWalter Ling, Larissa Mooney, Maureen Hillhouse
Drug and Alcohol Review|September 17, 2004
Substance use and treatment options in CambodiaRachel Humeniuk, Robert Ali, Walter Ling
Drug and Alcohol Dependence|March 24, 2004
Cochrane systematic reviews: time for an introduction and appraisalWalter Ling, Michael Farrell, Robert Ali
Journal of Psychoactive Drugs|July 29, 2004
Diffusion of substance abuse treatment: will buprenorphine be a success?Walter Ling, Jerry Cunningham-Rathner, Richard Rawson
Pageof 17